Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sukumar Nagendran currently holds 936,410 shares of Taysha Gene Therapies, Inc. (TSHA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sukumar Nagendran has been a net seller of TSHA stock. They have purchased $83.5K and sold $6.3M worth of shares.
Sukumar Nagendran's most recent insider trade was on Jul 10, 2026, when they sold 200,000 shares at $6.24 per share.
Sukumar Nagendran serves as Executive at Taysha Gene Therapies, Inc. (TSHA). They have executed 74 insider transactions totaling $6.4M over their tenure at the company.
Sukumar Nagendran holds the position of Executive at Taysha Gene Therapies, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Sukumar Nagendran has shown a selling trading pattern, with $83.5K in total purchases and $6.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Sukumar Nagendran was on Jul 10, 2026, when they sold $1.2M worth of TSHA shares. This transaction involved 200,000 shares at $6.24 per share.
Sukumar Nagendran currently owns 936,410 shares of Taysha Gene Therapies, Inc. (TSHA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sukumar Nagendran's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sukumar Nagendran has 74 Form 4 filings on record as an insider at Taysha Gene Therapies, Inc..
Set alerts for Sukumar Nagendran and 40,000+ other insiders.